4//SEC Filing
Protalix BioTherapeutics, Inc. 4
Accession 0001209191-09-049180
$PLXCIK 0001006281operating
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 8:44 PM ET
Size
8.0 KB
Accession
0001209191-09-049180
Insider Transaction Report
Form 4
Shaaltiel Yoseph
DirectorExecutive VP, R&D
Transactions
- Sale
Common Stock
2009-10-16$9.39/sh−25,680$241,135→ 1,306,874 total - Sale
Common Stock
2009-10-19$9.43/sh−43,120$406,622→ 1,263,754 total - Sale
Common Stock
2009-10-15$9.39/sh−31,200$292,968→ 1,332,554 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan
Documents
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001006281
Filing Metadata
- Form type
- 4
- Filed
- Oct 18, 8:00 PM ET
- Accepted
- Oct 19, 8:44 PM ET
- Size
- 8.0 KB